12:00 AM
 | 
May 28, 2012
 |  BC Week In Review  |  Company News  |  Deals

Epitarget deal

An undisclosed pharma company will supply custom short interfering RNA molecules for Epitarget to test on its ultrasound triggered siRNA...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >